Pharmaceutical intermediates
VONOPRAZAN FUMARATE Intermediates
11 pharmaceutical intermediates for VONOPRAZAN FUMARATE. Indication: Helicobacter Pylori Infection; Esophagitis; Gastroesophageal Reflux Disease.
About VONOPRAZAN FUMARATE
- Originator
- Takeda Pharmaceuticals
- Indication
- Helicobacter Pylori Infection; Esophagitis; Gastroesophageal Reflux Disease
- Approved Date
- 05/03/2022
- NCE Patent
- 05/03/2027
- DS/DP
- 08/11/2025
Available intermediates
11 intermediates currently listed for VONOPRAZAN FUMARATE. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile | 1240948-77-9 | / | / |
| 2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile | 1240948-72-4 | / | / |
| 5-(2-fluorophenyl)-1H-pyrrole-3-carboxylic acid methyl ester | 1240949-59-0 | / | / |
| 2-[2-(2-Fluorophenyl)-2-oxoethyl]propanedinitrile | 312307-38-3 | / | / |
| pyridine-3-sulfonyl chloride | 16133-25-8 | / | / |
| 1H-Pyrrole-3-carboxylic acid, 5-(2-fluorophenyl)-, ethyl ester | 881674-06-2 | / | / |
| 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | 881674-56-2 | / | / |
| 5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde | 881677-11-8 | / | / |
| Vonoprazan | 881681-00-1 | / | / |
| 3-Pyridinesulfonyl chloride | 16133-25-8 | / | / |
| 5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde | 881674-56-2 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →